PTC Therapeutics | PTCT - 销售和管理费用



金融业
股票价格
USD
资产
USD 2.87B
现金及等价物
USD 833.99M
销售成本
USD 39.61M
流动资产
USD 2.25B
流动负债
USD 923.6M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -0.03
股本和储备
USD -180.47M
销售毛利
USD 232.94M
债务利息支出
USD 2.87B
贷款资金
USD 286.94M
市值
USD 5.27B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -2.46M
销售收入
USD 273M
销售和管理费用
USD 73.89M
股票
USD 75.57M
贸易债权人
USD 25.48M
应收帐款人
USD 181.62M


销售和管理费用 更改 日
Acadia Pharmaceuticals USD 160.79M 14.06M 2026-03
Alnylam Pharmaceuticals USD 282.51M 2.55M 2026-03
Amgen USD 1.58B 354M 2026-03
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
Biogen USD 554.3M 128.2M 2026-03
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Cytokinetics USD 104.9M 13.17M 2026-03
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Esperion Therapeutics USD 39.42M 456K 2025-12
Gilead Sciences USD 1.45B 326M 2026-03
Incyte USD 328.1M 62.31M 2026-03
Ionis Pharmaceuticals USD 151M 21M 2026-03
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Novartis USD 3.14B 296M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
PTC Therapeutics USD 73.89M 13.31M 2026-03
Puma Biotechnology USD 16.82M 8.15M 2024-09
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 54.03M 51.35M 2026-03
TG Therapeutics USD 73.14M 22.42M 2026-03
Ultragenyx Pharmaceutical USD 88M 1000K 2026-03
Vertex Pharmaceuticals USD 493.7M 6.7M 2026-03
Xencor USD 82.12M 65.08M 2026-03